de la Torre, A. (2023) “Evolving role of novel therapies in myeloma: T-cell engagers and antibody-drug conjugates”, Canadian Hematology Today. Toronto, Canada, 2(2), pp. 16–19. doi: 10.58931/cht.2023.2233.